The size of the Europe Active Implantable Medical Devices Market is valued at USD 5.53 billion in 2022. This value is expected to reach USD 8.08 billion by 2027 to get a 7.86% CAGR during the forecast period. Europe was the second-largest region following North America in the European active implantable medical devices market during the forecast period. Increase in the elder people population, a frequent rise in cardiovascular and neurological diseases propelling the market growth.
Rising funds and investments for more advanced technological products, the growing stress of cardiovascular diseases, and increasing the regularity of neurological disorders propel market growth. The growing number of accidents and injuries is also significantly contributing to the European market. The ever-increasing number of organ failures and the shortage of dearth of organ donors is estimated to augment this region's market. The rising elder people population is witnessing high and regular osteoarthritis and orthopedic injuries requiring implantable orthopedic devices. This factor is estimated to surge the market's growth rate.
The High costs related to implantable medical devices, lack of experienced professionals, and high burden and stress on industries may hinder the market. Inexpedient reimbursement policies may obstruct the market.
This research report on the Europe Active Implantable Medical Devices Market report has been segmented and sub-segmented into the following categories:
Based on the region, Europe held the second-largest share in the regional segment of the market. It can be credited to the growth in the geriatric population, increase in the prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increased development of innovative and technologically advanced products and increased healthcare expenditure in the region.
The German market is projected to dominate the European market during the forecast period. The massive availability of advanced technologies, growing expenses in healthcare, increasing income levels, and demand for large implants demand to escalate the market demand in the European region.
The UK's active implantable medical devices market is witnessed to have robust growth during the forecast period. Increasing demand is mounting because of increasing regular cardiovascular diseases and growing occurrence rates of neurological disorders, fueling the region's market. Raising funds and investments in developing more advanced technological products, increasing utilization and applications of neurostimulators, and favorable reimbursement for ENT processes among the developed countries is considered to boost the market growth during the period.
France is expected to have a significant growth rate in the market in the upcoming years.
Some of the top companies leading the Europe Active Implantable Medical Devices Market profiled in the report are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC., Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S, and Nurotron Biotechnology Co. Ltd.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org